Trademark: ONCXERNA 2142278
Word
ONCXERNA
Device Descrption:
ANGLED & OBLIQUE STRIPES FORM LTR X
ID
2142278
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
03 November 2020
Registration Date
03 November 2020
Renewal Date
03 November 2030
Owner(s)
Service
Goods and Services:
Class 1:
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer.
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer.
Class 5:
Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use.
Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use.